Prakash Abraham

ORCID: 0000-0003-1195-8188
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pituitary Gland Disorders and Treatments
  • Thyroid Disorders and Treatments
  • Adrenal and Paraganglionic Tumors
  • Growth Hormone and Insulin-like Growth Factors
  • Thyroid Cancer Diagnosis and Treatment
  • Adrenal Hormones and Disorders
  • Ophthalmology and Eye Disorders
  • Hormonal Regulation and Hypertension
  • Radiation Dose and Imaging
  • Glioma Diagnosis and Treatment
  • Diabetes Management and Research
  • Diet and metabolism studies
  • Myasthenia Gravis and Thymoma
  • Neuroblastoma Research and Treatments
  • Diabetes Management and Education
  • Cancer, Hypoxia, and Metabolism
  • Diabetes Treatment and Management
  • Neuroendocrine Tumor Research Advances
  • Food composition and properties
  • Biomedical Text Mining and Ontologies
  • Chronic Disease Management Strategies
  • Cardiovascular Disease and Adiposity
  • Diabetes and associated disorders
  • Restraint-Related Deaths
  • Medical Imaging Techniques and Applications

Aberdeen Royal Infirmary
2011-2025

Chelsea and Westminster Hospital
2024

Ninewells Hospital
2024

NHS Grampian
2005-2024

University of Aberdeen
2020

Cambridge University Press
2015

New York University Press
2015

Royal Hallamshire Hospital
2009

Sheffield Teaching Hospitals NHS Foundation Trust
2009

Pedro Marques Francisca Caimari Laura C. Hernández‐Ramírez David Collier Donato Iacovazzo and 95 more Amy Ronaldson Kesson Magid Chung Thong Lim Karen Stals Sian Ellard Ashley Grossman Márta Korbonits Prakash Abraham Elena Daniela Aflorei Amar Agha James Ahlquist Scott Akker Krystallenia Alexandraki Sándor Alföldi João Anselmo Wiebke Arlt Brew Atkinson Anna Aulinas-Masó Simon Aylwin Atik Baborie Philippe Backeljauw Corin Badiu Stephanie Baldeweg Steve Ball Gul Bano Ariel Barkan John Barton Julian Barwell P. C. Bates Carmen Bernal-González Michael Besser John S. Bevan Alex Bickerton Joanne Blair Marek Bolanowski Pierre Bouloux Lisa Bradley Karin Bradley Caroline Brain Antonia Brooke Roger Brown Michael Buchfelder Christine Burren Mehtap Çakır Natalie Canham Joël Capraro Paul Carroll Philippa Carter David Carty Dominic Cavlan Harvinder Chahal Tim Cheetham F. Chentli Catherine S. Choong Mirjam Christ‐Crain Teng‐Teng Chung Peter Clayton Richard N. Clayton Mark L. Cohen Hamish Courtney David J. Cove Elizabeth Crowne Daniel J. Cuthbertson Jacob Dal Nadezhda Dalantaeva Svetozar Damjanović Christina Daousi Ken Darzy Mehul Dattani Michaela Davies Justin Davies J.R. Davis Margaret de Castro Laura De Marinis Cheri Deal Judit Dénes Paul Dimitri Neil Dorward Graham Dow William Drake Maralyn Druce Juliana Drummond Pinaki Dutta Larisa Dzeranova Britt Edén Engström Rosalind A. Eeles Maria Elfving Kate Ellis Marianne S. Elston Louise Emmerson Shereen Ezzat Naomi Fersht Simona Fica Stefan Fischli Maria Fleseriu

Abstract Context Germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene are responsible for a subset of familial isolated pituitary adenoma (FIPA) cases and sporadic neuroendocrine tumors (PitNETs). Objective To compare prospectively diagnosed AIP mutation-positive (AIPmut) PitNET patients with clinically presenting to clinical characteristics AIPmut AIPneg patients. Design 12-year prospective, observational study. Participants & Setting We studied probands...

10.1210/clinem/dgaa040 article EN cc-by The Journal of Clinical Endocrinology & Metabolism 2020-01-30

Abstract Objective The optimal approach to the surveillance of non-functioning pituitary microadenomas (micro-NFPAs) is not clearly established. Our aim was generate evidence on natural history micro-NFPAs support patient care. Design Multi-centre, retrospective, cohort study involving 23 endocrine departments (UK NFPA consortium). Methods Clinical, imaging, and hormonal data micro-NFPA cases between January, 1, 2008 December, 21, 2021 were analysed. Results Data for 459 patients retrieved...

10.1093/ejendo/lvad070 article EN cc-by European Journal of Endocrinology 2023-06-22

Summary Background A survey of physicians’ practice relating to radioiodine administration for hyperthyroidism was carried out in the UK over 15 years ago and showed wide variations patient management. This led development national guidelines use hyperthyroidism. As there have been significant advances field since that survey, we another study prevalent practices therapy benign thyroid disorders across UK. Subjects methods We mailed 698 consultant endocrinologists a questionnaire on...

10.1111/j.1365-2265.2007.03097.x article EN Clinical Endocrinology 2007-10-08

Abstract: Radioiodine, antithyroid drugs and surgery have been well established therapies for Graves' hyperthyroidism several decades. However there remain large variations in practice among physicians the preferred modality method of administration. Patient choice perceptions also play a big role treatment. Radioiodine may be given using fixed high doses or by calculated following uptake studies. The risks radioiodine including eye disease prophylactic steroid therapy are discussed....

10.2147/tcrm.s5229 article EN cc-by-nc Therapeutics and Clinical Risk Management 2009-12-01

Abstract Aims In the UK , lifestyle intervention is first‐line management in Type 2 diabetes. It unclear what type of diet most efficacious for improving glycaemic control. This study investigated effects an oat‐enriched on control, postprandial glycaemia, inflammation and oxidative stress compared with standard dietary advice. Methods a randomized crossover design, 27 volunteers diabetes, managed only, were observed two consecutive 8‐week periods following either or re‐enforced Volunteers...

10.1111/dme.12228 article EN Diabetic Medicine 2013-05-14

Scope Inflammatory status can increase the risk of adverse cardiovascular events linked to platelet activity and involvement microparticles (MP) released from platelets (PMP), leukocytes (LMP), monocytes (MMP). These MP carry host cell-derived antigens that may act as markers metabolic health. Subjects newly diagnosed with type 2 diabetes are offered appropriate standard dietary advice (SDA) but this not be optimal specific inclusion other nutrients, such oats, add benefit. The effectiveness...

10.1002/mnfr.201300820 article EN cc-by Molecular Nutrition & Food Research 2014-03-07

Surveillance is often adopted for asymptomatic non-functioning pituitary macroadenomas (macroNFPAs). Due to low quality evidence, uncertainty remains on optimal frequency of imaging/biochemical monitoring and indications surgery. We assessed the natural history outcomes patients with macroNFPA who had as initial management choice from UK NFPA Consortium. Multicentre, retrospective, cohort study involving 21 endocrine departments. Clinical, imaging, hormonal data 949 followed-up between...

10.1093/ejendo/lvaf091 article EN European Journal of Endocrinology 2025-04-29

This study determined the cost effectiveness of treating thyrotoxicosis using thionamide therapy, radioiodine or surgery in United Kingdom.One hundred thirty-five patients diagnosed with (62% Graves' disease, 7% nodular 5% thyroiditis, and 27% unknown aetiology) referred 12 months were offered a fully informed choice treatment modality. Thirteen transient subsequently excluded from analysis. Seventy-four (61%) received an 18-month course 43 therapy (35%), 5 had thyroidectomy (4%) within...

10.1089/thy.2006.16.593 article EN Thyroid 2006-06-01

Background: While few hypothyroid patients require more than the expected weight-related dose of levothyroxine, underlying causes larger-than-expected dosing requirements have not been studied in a single cohort. Our aim was to determine and quantify multiple factors contributing high-dose levothyroxine cohort with hypothyroidism. Methods: The Grampian Automated Follow-Up Register (GAFUR) monitors around 17,500 patients. In 2008, 190 (1%) took >225 μg daily. A questionnaire sent 174 (16 were...

10.1089/thy.2013.0661 article EN Thyroid 2014-10-27

Summary The new European Society of Endocrinology guidelines on the management adrenal incidentalomas suggest discussion in a multidisciplinary meeting and consideration additional imaging for homogenous lesions with density >20 Hounsfield units (HU) size <4 cm. We report case 29-year-old woman who presented benign-looking lesion CT adrenals based washout values, which was diagnosed as malignant subsequent imaging. Initial hormonal work-up normal. Two years later, had grown to 17 × 11...

10.1530/edm-24-0022 article EN cc-by-nc-nd Endocrinology Diabetes and Metabolism Case Reports 2025-04-01

ABSTRACT Background Recent years have seen changes and uncertainties in evidence guideline recommendations Graves' disease treatment. To understand the impact of these developments on current practice, we undertook a survey management United Kingdom compared this to other national international surveys. Method Members British Thyroid Association, UK Society for Endocrinology regional endocrinology networks, were invited by e‐mail complete 15‐min online (October 2022 March 2023). Results Out...

10.1111/cen.15266 article EN cc-by Clinical Endocrinology 2025-05-08

Adrenal phaeochromocytoma rarely causes ectopic ACTH syndrome. We describe a 44-yr-old hypertensive woman who was Cushingoid and markedly pigmented. Laboratory studies indicated severe hypokalaemia, abnormal liver function tests, random serum cortisols greater than 1660 nmol/L. Urinary catecholamines were increased. An abdominal computed tomography scan showed 4-cm left adrenal mass an hypertrophied right adrenal. levels elevated at 200 pmol/L, but precursors, which cross-react in the assay,...

10.1210/jcem.85.12.7047 article EN The Journal of Clinical Endocrinology & Metabolism 2000-12-01

Abstract Severe hypercalcaemia during pregnancy is rare and most cases are secondary to hyperparathyroidism. This the first report of a parathyroid hormone related protein (PTHrP) secreting neuroendocrine tumour pancreas manifesting with severe pregnancy. Measurement PTHrP was useful in both diagnosis follow up our patient should be considered diagnostic workup patients unexplained hypercalcaemia. A raised concentration strong indicator malignancy.

10.1136/pmj.78.926.752 article EN Postgraduate Medical Journal 2002-12-01

Abstract The effects of fish oil (FO) supplementation on glycaemic control are unclear, and positive may occur only when the phospholipid content tissue membranes exceeds 14 % as n -3 PUFA. Subjects ( 36, thirty-three completed) were paired based metabolic parameters allocated into a parallel double-blind randomised trial with one each pair offered daily either 6 g FO (3·9 PUFA) or maize (MO) for 9 months. Hyperinsulinaemic–euglycaemic–euaminoacidaemic (HIEGEAA) clamps (with [6,6 2 H...

10.1017/s0007114515004274 article EN British Journal Of Nutrition 2015-11-05
Coming Soon ...